Catheter ablation of atrial fibrillation in patients at low thrombo-embolic risk: Efficacy and safety of a simplified periprocedural anticoagulation strategy

Journal of Cardiovascular Electrophysiology

Volumn 24, Issue 8, 2013, Pages 855-860

  Duytschaever, Mattias ^a   Berte, Benjamin ^a   Acena, Marta ^a   De Meyer, Grim ^a   Bun, Sok Sithikun ^a   Van Heuverswyn, Frederic ^b   Vandekerckhove, Yves ^a   Tavernier, Rene ^a  

^a General Hospital St Jan   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

anticoagulation; atrial fibrillation; catheter ablation; CHADS; stroke

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; NADROPARIN;

ADULT; ANTICOAGULANT THERAPY; ANTICOAGULATION; ARTICLE; CARDIOVASCULAR RISK; CATHETER ABLATION; CATHETER COMPLICATION; CHADS2 SCORE; DRUG EFFICACY; DRUG SAFETY; FALSE ANEURYSM; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART TAMPONADE; HEMATOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT SAFETY; PERICARDIAL EFFUSION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURGICAL DRAINAGE; THROMBOEMBOLISM; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT DURATION;

ANTICOAGULATION; ATRIAL FIBRILLATION; CATHETER ABLATION; CHADS; STROKE;

ANTICOAGULANTS; ASPIRIN; ATRIAL FIBRILLATION; CATHETER ABLATION; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; PULMONARY VEINS; RECURRENCE; RISK; STROKE; THROMBOEMBOLISM; TREATMENT OUTCOME;

EID: 84880638503     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/jce.12148     Document Type: Article

References (37)

1. Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, Crijns HJ, Damiano RJ Jr, Davies DW, DiMarco J, Edgerton J, Ellenbogen K, Ezekowitz MD, Haines DE, Haissaguerre M, Hindricks G, Iesaka Y, Jackman W, Jalife J, Jais P, Kalman J, Keane D, Kim YH, Kirchhof P, Klein G, Kottkamp H, Kumagai K, Lindsay BD, Mansour M, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Nakagawa H, Natale A, Nattel S, Packer DL, Pappone C, Prystowsky E, Raviele A, Reddy V, Ruskin JN, Shemin RJ, Tsao HM, Wilber D,: 2012 HRS/EHRA/ECAS Expert Consensus statement on catheter and surgical ablation of atrial fibrillation: Recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Heart Rhythm 2012; 9: 632-696.
2. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL,: American College of Cardiology/American Heart Association Task Force on Practice Guidelines; European Society of Cardiology Committee for Practice Guidelines; European Heart Rhythm Association; Heart Rhythm Society: ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation): Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006; 114: e257-e354.
3. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Le Heuzey JY, Ponikowski P, Rutten FH,: Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010; 31: 2369-2429.
4. You JJ, Singer DE, Howard PA, Lane DA, Eckman MH, Fang MC, Hylek EM, Schulman S, Go AS, Hughes M, Spencer FA, Manning WJ, Halperin JL, Lip GYH, MD,: Antithrombotic therapy for atrial fibrillation. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (Suppl.): e531S-e575S.
5. Haïssaguerre M, Jaïs P, Shah DC, Garrigue S, Takahashi A, Lavergne T, Hocini M, Peng JT, Roudaut R, Clémenty J,: Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci. Circulation 2000; 101: 1409-1417.
6. Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, Kim YH, Klein G, Packer D, Skanes A,: Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation 2005; 111: 1100-1105.
7. Kok LC, Mangrum JM, Haines DE, Mounsey JP,: Cerebrovascular complication associated with pulmonary vein ablation. J Cardiovasc Electrophysiol 2002; 13: 764-767.
8. Anné W, Tavernier R, Duytschaever M,: Four types of complications in paroxysmal atrial fibrillation ablation. Europace 2010; 12: 337-341.
9. Dagres N, Hindricks G, Kottkamp H, Sommer P, Gaspar T, Bode K, Arya A, Husser D, Rallidis LS, Kremastinos DT, Piorkowski C,: Complications of atrial fibrillation ablation in a high-volume center in 1,000 procedures: Still cause for concern? J Cardiovasc Electrophysiol 2009; 20: 1014-1019.
10. Ren JF, Marchlinski FE, Callans DJ, Gerstenfeld EP, Dixit S, Lin D, Nayak HM, Hsia HH,: Increased intensity of anticoagulation may reduce risk of thrombus during atrial fibrillation ablation procedures in patients with spontaneous echo contrast. J Cardiovasc Electrophysiol 2005; 16: 474-477.
11. Bruce CJ, Friedman PA, Narayan O, Munger TM, Hammill SC, Packer DL, Asirvatham SJ,: Early heparinization decreases the incidence of left atrial thrombi detected by intracardiac echocardiography during radiofrequency ablation for atrial fibrillation. J Interv Card Electrophysiol 2008; 22: 211-219.
12. Hussein AA, Martin DO, Saliba W, Patel D, Karim S, Batal O, Banna M, Williams-Andrews M, Sherman M, Kanj M, Bhargava M, Dresing T, Callahan T, Tchou P, Di Biase L, Beheiry S, Lindsay B, Natale A, Wazni O,: Radiofrequency ablation of atrial fibrillation under therapeutic international normalized ratio: A safe and efficacious periprocedural anticoagulation strategy. Heart Rhythm 2009; 6: 1425-1429.
13. Gopinath D, Lewis WR, Di Biase L, Natale A,: Pulmonary vein antrum isolation for atrial fibrillation on therapeutic coumadin: Special considerations. J Cardiovasc Electrophysiol 2011; 22: 236-239.
14. Mortada ME, Chandrasekaran K, Nangia V, Dhala A, Blanck Z, Cooley R, Bhatia A, Gilbert C, Akhtar M, Sra J,: Periprocedural anticoagulation for atrial fibrillation ablation. J Cardiovasc Electrophysiol 2008; 19: 362-366.
15. Di Biase L, Burkhardt JD, Mohanty P, Sanchez J, Horton R, Gallinghouse GJ, Lakkireddy D, Verma A, Khaykin Y, Hongo R, Hao S, Beheiry S, Pelargonio G, Dello Russo A, Casella M, Santarelli P, Santangeli P, Wang P, Al-Ahmad A, Patel D, Themistoclakis S, Bonso A, Rossillo A, Corrado A, Raviele A, Cummings JE, Schweikert RA, Lewis WR, Natale A,: Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: The impact of periprocedural therapeutic international normalized ratio. Circulation 2010; 121: 2550-2556.
16. Bunch TJ, Crandall BG, Weiss JP, May HT, Bair TL, Osborn JS, Anderson JL, Lappe DL, Muhlestein JB, Nelson J, Allison S, Foley T, Anderson L, Day JD,: Warfarin is not needed in low-risk patients following atrial fibrillation ablation procedures. J Cardiovasc Electrophysiol 2009; 20: 988-993.
17. Wilber DJ, Pappone C, Neuzil P, De Paola A, Marchlinski F, Natale A, Macle L, Daoud EG, Calkins H, Hall B, Reddy V, Augello G, Reynolds MR, Vinekar C, Liu CY, Berry SM, Berry DA,: Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: A randomized controlled trial. JAMA 2010; 303: 333-340.
18. Stabile G, Bertaglia E, Senatore G, De Simone A, Zoppo F, Donnici G, Turco P, Pascotto P, Fazzari M, Vitale DF,: Catheter ablation treatment in patients with drug-refractory atrial fibrillation: A prospective, multi-centre, randomized, controlled study (Catheter Ablation for the Cure of Atrial Fibrillation study). Eur Heart J 2006; 27: 216-221.
19. Jaïs P, Cauchemez B, Macle L, Daoud E, Khairy P, Subbiah R, Hocini M, Extramiana F, Sacher F, Bordachar P, Klein G, Weerasooriya R, Clémenty J, Haïssaguerre M,: Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: The A4 study. Circulation 2008; 118: 2498-2505.
20. 2 score in the evaluation of thromboembolic risk in patients with atrial fibrillation undergoing transesophageal echocardiography before pulmonary vein isolation. J Am Coll Cardiol 2009; 54: 2032-2039.
21. Kongsgaard E, Foerster A, Aass H, Madsen S, Amlie JP,: Power and temperature guided radiofrequency catheter ablation of the right atrium in pigs. Pacing Clin Electrophysiol 1994; 17: 1610-1620.
22. Manolis AS, Melita-Manolis H, Vassilikos V, Maounis T, Chiladakis J, Christopoulou-Cokkinou V, Cokkinos DV,: Thrombogenicity of radiofrequency lesions: Results with serial D-dimer determinations. J Am Coll Cardiol 1996; 28: 1257-1261.
23. Lijnen HR, Collen D,: Endothelium in hemostasis and thrombosis. Prog Cardiovasc Dis 1997; 39: 343-350.
24. Huang SK, Bharati S, Lev M, Marcus FI,: Electrophysiologic and histologic observations of chronic atrioventricular block induced by closed-chest catheter desiccation with radiofrequency energy. Pacing Clin Electrophysiol 1987; 10: 805-816.
25. Oral H, Chugh A, Ozaydin M, Good E, Fortino J, Sankaran S, Reich S, Igic P, Elmouchi D, Tschopp D, Wimmer A, Dey S, Crawford T, Pelosi F Jr, Jongnarangsin K, Bogun F, Morady F,: Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation. Circulation 2006; 114: 759-765.
26. Brueckmann M, Wolpert C, Bertsch T, Sueselbeck T, Liebetrau C, Kaden JJ, Huhle G, Neumaier M, Borggrefe M, Haase KK,: Markers of myocardial damage, tissue healing, and inflammation after radiofrequency catheter ablation of atrial tachyarrhythmias. J Cardiovasc Electrophysiol 2004; 15: 686-691.
27. Gaita F, Leclercq JF, Schumacher B, Scaglione M, Toso E, Halimi F, Schade A, Froehner S, Ziegler V, Sergi D, Cesarani F, Blandino A,: Incidence of silent cerebral thromboembolic lesions after atrial fibrillation ablation may change according to technology used: Comparison of irrigated radiofrequency, multipolar nonirrigated catheter and cryoballoon. J Cardiovasc Electrophysiol 2011; 22: 961-968.
28. Khairy P, Chauvet P, Lehmann J, Lambert J, Macle L, Tanguay JF, Sirois MG, Santoianni D, Dubuc M,: Lower incidence of thrombus formation with cryoenergy versus radiofrequency catheter ablation. Circulation 2003; 107: 2045-2050.
29. 2-VASc scores in the prediction of clinical outcomes in patients with atrial fibrillation after catheter ablation. J Am Coll Cardiol 2011; 23: 2380-2385.
30. Scherr D, Sharma K, Dalal D, Spragg D, Chilukuri K, Cheng A, Dong J, Henrikson CA, Nazarian S, Berger RD, Calkins H, Marine JE,: Incidence and predictors of periprocedural cerebrovascular accident in patients undergoing catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol 2009; 20: 379-384.
31. Hoyt H, Bhonsale A, Chilukuri K, Alhumaid F, Needleman M, Edwards D, Govil A, Nazarian S, Cheng A, Henrikson CA, Sinha S, Marine JE, Berger R, Calkins H, Spragg DD,: Complications arising from catheter ablation of atrial fibrillation: Temporal trends and predictors. Heart Rhythm 2011; 8: 1869-1874.
32. Ren JF, Marchlinski FE, Callans DJ,: Left atrial thrombus associated with ablation for atrial fibrillation: Identification with intracardiac echocardiography. J Am Coll Cardiol 2004; 43: 1861-1867.
33. Lee G, Sparks PB, Morton JB, Kistler PM, Vohra JK, Medi C, Rosso R, Teh A, Halloran K, Kalman JM,: Low risk of major complications associated with pulmonary vein antral isolation for atrial fibrillation: Results of 500 consecutive ablation procedures in patients with low prevalence of structural heart disease from a single center. J Cardiovasc Electrophysiol 2011; 22: 163-168.
34. Manolis AS, Vassilikos V, Maounis TN, Psarros L, Melita-Manolis H, Papatheou D, Haliassos A, Christopoulou-Cokkinou V, Cokkinos DV,: Pretreatment with aspirin and ticlopidine confers lower thrombogenic potential of radiofrequency catheter ablation. Am J Cardiol 1997; 79: 494-497.
35. Connolly SJ, Eikelboom J, Joyner C, Diener HC, Hart R, Golitsyn S, Flaker G, Avezum A, Hohnloser SH, Diaz R, Talajic M, Zhu J, Pais P, Budaj A, Parkhomenko A, Jansky P, Commerford P, Tan RS, Sim KH, Lewis BS, Van Mieghem W, Lip GY, Kim JH, Lanas-Zanetti F, Gonzalez-Hermosillo A, Dans AL, Munawar M, O'Donnell M, Lawrence J, Lewis G, Afzal R, Yusuf S,; AVERROES Steering Committee and Investigators: Apixaban in patients with atrial fibrillation. N Engl J Med 2011; 364: 806-817.
36. Lakkireddy D, Reddy YM, Di Biase L, Vanga SR, Santangeli P, Swarup V, Pimentel R, Mansour MC, D'Avila A, Sanchez JE, Burkhardt JD, Chalhoub F, Mohanty P, Coffey J, Shaik N, Monir G, Reddy VY, Ruskin J, Natale A,: Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: Results from a multicenter prospective registry. J Am Coll Cardiol 2012; 59: 1168-1174.
37. Winkle RA, Mead RH, Engel G, Kong MH, Patrawala RA,. The use of dabigatran immediately after atrial fibrillation ablation. J Cardiovasc Electrophysiol 2012; 23: 264-268.